308 related articles for article (PubMed ID: 35137398)
41. Early Identification of Chronic Lung Allograft Dysfunction: The Need of Biomarkers.
Tissot A; Danger R; Claustre J; Magnan A; Brouard S
Front Immunol; 2019; 10():1681. PubMed ID: 31379869
[TBL] [Abstract][Full Text] [Related]
42. Elevated bronchoalveolar lavage eosinophilia correlates with poor outcome after lung transplantation.
Verleden SE; Ruttens D; Vandermeulen E; van Raemdonck DE; Vanaudenaerde BM; Verleden GM; Vos R
Transplantation; 2014 Jan; 97(1):83-9. PubMed ID: 24157472
[TBL] [Abstract][Full Text] [Related]
43. Impact of statin treatment and exposure on the risk of chronic allograft dysfunction in Chinese lung transplant recipients.
Zhang D; Wang X; Du W; Qin W; Chen W; Zuo X; Li P
Pulm Pharmacol Ther; 2023 Oct; 82():102243. PubMed ID: 37454870
[TBL] [Abstract][Full Text] [Related]
44. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
[TBL] [Abstract][Full Text] [Related]
45. Chronic lung allograft dysfunction: evolving practice.
Vos R; Verleden SE; Verleden GM
Curr Opin Organ Transplant; 2015 Oct; 20(5):483-91. PubMed ID: 26262458
[TBL] [Abstract][Full Text] [Related]
46. Chronic lung allograft dysfunction and restrictive allograft syndrome: are phenotypes robust and helpful?
Verleden GM; Godinas L; Vos R; Verleden SE
Curr Opin Organ Transplant; 2022 Jun; 27(3):211-216. PubMed ID: 35649111
[TBL] [Abstract][Full Text] [Related]
47. Relationship between immune cells and the development of chronic lung allograft dysfunction.
Ye D; Liu Q; Zhang C; Dai E; Fan J; Wu L
Int Immunopharmacol; 2024 Jun; 137():112381. PubMed ID: 38865754
[TBL] [Abstract][Full Text] [Related]
48. The pulmonary microbiome: recent advances in understanding its role in chronic lung allograft dysfunction.
Mitchell AB; Glanville AR
Curr Opin Organ Transplant; 2022 Jun; 27(3):217-221. PubMed ID: 35649112
[TBL] [Abstract][Full Text] [Related]
49. [Chronic lung allograft dysfunction in 2022, past and updates].
Halitim P; Tissot A
Rev Mal Respir; 2023 Apr; 40(4):324-334. PubMed ID: 36858879
[TBL] [Abstract][Full Text] [Related]
50. Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.
Suwara MI; Vanaudenaerde BM; Verleden SE; Vos R; Green NJ; Ward C; Borthwick LA; Vandermeulen E; Lordan J; Van Raemdonck DE; Corris PA; Verleden GM; Fisher AJ
Transpl Int; 2014 Aug; 27(8):857-67. PubMed ID: 24750386
[TBL] [Abstract][Full Text] [Related]
51. Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation.
Verleden SE; Ruttens D; Vandermeulen E; Bellon H; Dubbeldam A; De Wever W; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM; Benden C; Vos R
J Heart Lung Transplant; 2016 Sep; 35(9):1078-84. PubMed ID: 27212563
[TBL] [Abstract][Full Text] [Related]
52. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
[TBL] [Abstract][Full Text] [Related]
53. MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction.
Miyahara N; Benazzo A; Oberndorfer F; Iwasaki A; Laszlo V; Döme B; Hoda MA; Jaksch P; Klepetko W; Hoetzenecker K
Transpl Int; 2021; 35():10184. PubMed ID: 35185369
[No Abstract] [Full Text] [Related]
54. Adaptive and innate immune responses in a rat orthotopic lung transplant model of chronic lung allograft dysfunction.
Evers A; Atanasova S; Fuchs-Moll G; Petri K; Wilker S; Zakrzewicz A; Hirschburger M; Padberg W; Grau V
Transpl Int; 2015 Jan; 28(1):95-107. PubMed ID: 25179205
[TBL] [Abstract][Full Text] [Related]
55. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
[TBL] [Abstract][Full Text] [Related]
56. Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center study.
Verleden SE; Von Der Thüsen J; Van Herck A; Weynand B; Verbeken E; Verschakelen J; Dubbeldam A; Vanaudenaerde BM; Vos R; Verleden GM;
Clin Transplant; 2020 Feb; 34(2):e13781. PubMed ID: 31958356
[TBL] [Abstract][Full Text] [Related]
57. Early onset of azithromycin to prevent CLAD in lung transplantation: Promising results of a retrospective single centre experience.
Cristeto Porras M; Mora Cuesta VM; Iturbe Fernández D; Tello Mena S; Alonso Lecue P; Sánchez Moreno L; Miñambres García E; Naranjo Gozalo S; Izquierdo Cuervo S; Cifrián Martínez JM
Clin Transplant; 2023 Jan; 37(1):e14832. PubMed ID: 36217992
[TBL] [Abstract][Full Text] [Related]
58. N-myc-interactor mediates microbiome induced epithelial to mesenchymal transition and is associated with chronic lung allograft dysfunction.
Banday MM; Kumar A; Vestal G; Sethi J; Patel KN; O'Neill EB; Finan J; Cheng F; Lin M; Davis NM; Goldberg H; Coppolino A; Mallidi HR; Dunning J; Visner G; Gaggar A; Seyfang A; Sharma NS
J Heart Lung Transplant; 2021 Jun; 40(6):447-457. PubMed ID: 33781665
[TBL] [Abstract][Full Text] [Related]
59. Fungal infection and colonization in lung transplant recipients with chronic lung allograft dysfunction.
Pennington KM; Aversa M; Martinu T; Johnson B; Husain S
Transpl Infect Dis; 2022 Dec; 24(6):e13986. PubMed ID: 36380578
[TBL] [Abstract][Full Text] [Related]
60. Functional and computed tomographic evolution and survival of restrictive allograft syndrome after lung transplantation.
Verleden SE; de Jong PA; Ruttens D; Vandermeulen E; van Raemdonck DE; Verschakelen J; Vanaudenaerde BM; Verleden GM; Vos R
J Heart Lung Transplant; 2014 Mar; 33(3):270-7. PubMed ID: 24461432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
